Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily S. Pfeiffer
Replacement of ParC 4 Helix With That of GyrA Increases the Stability and Cytotoxicity of Topoisomerase IV-Quinolone-DNA Ternary Complexes
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Alterations in the GyrA Subunit of DNA Gyrase and the ParC Subunit of DNA Topoisomerase IV Associated With Quinolone Resistance in Enterococcus Faecalis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Prevalence of Mutations Within the Quinolone Resistance-Determining Region of gyrA, gyrB, parC, and parE and Association With Antibiotic Resistance in Quinolone-Resistant Salmonella Enterica
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Cloning and Characterization of the parC and parE Genes of Streptococcus Pneumoniae Encoding DNA Topoisomerase IV: Role in Fluoroquinolone Resistance.
Journal of Bacteriology
Microbiology
Molecular Biology
Cloning and Nucleotide Sequences of the Topoisomerase IV parC and parE Genes ofMycoplasma Hominis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Staphylococcus aureusGyrase-Quinolone-DNA Ternary Complexes Fail to Arrest Replication Fork Progressionin Vitro
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Importance of the Fourth Alpha-Helix Within the CAP Homology Domain of Type II Topoisomerase for DNA Cleavage Site Recognition and Quinolone Action
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mutations in Topoisomerase IV and DNA Gyrase ofStaphylococcus Aureus: Novel Pleiotropic Effects on Quinolone and Coumarin Activity
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter Baumannii Resistant to Fluoroquinolone
Open Microbiology Journal
Immunology
Microbiology
Improved Antimicrobial Activity of DU-6859a, a New Fluoroquinolone, Against Quinolone-Resistant Klebsiella Pneumoniae and Enterobacter Cloacae Isolates With Alterations in GyrA and ParC Proteins.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
